Risk Assessment Strategy / Tools & Technology

Topic	Replies	Views	Activity
Carcinogenic Potency Database - Access free With discussions about limits and how they are establish, it’s an important reminder about the Carcinogenic Potency Database, now The Lhasa Carcinogenicity Database (LCDB). Below from Lhasa article: “5 things you should…	3	2496	August 22, 2022
About the Risk Assessment Strategy / Tools & Technology category	0	659	April 14, 2021
Less than daily administration	1	142	July 10, 2026
QSAR Toolbox - Free software. Any experience?	21	2472	June 27, 2026
Nitrosamine risk assessment in early clinical development	0	175	June 17, 2026
Removal of nitrosamine analysis from the specification	3	256	April 24, 2026
Excipient Selection Strategies to Mitigate Nitrosamine Risks Excipients	0	221	April 8, 2026
Excipient Nitrosamine Risk Assessment Tool	1	544	March 26, 2026
Limit Test for NDSRI Risk Assessment?	3	223	March 13, 2026
Chat GPT's answer about the risk assessment of nitrosamine in pharmaceuticals	33	4045	February 28, 2026
Nitrosamine Risk Assessment on DETA	0	157	February 22, 2026
Available Tools for Prediction of Potential Degradation Products from Nitrosation Reactions Drug_Substance_APIs , risk-assessment , NDSRI	4	311	February 4, 2026
Nitrosamine Purge Factor Calculation Drug_Substance_APIs	1	499	December 30, 2025
The Impact of API Synthesis Optimization on Reducing Nitrosamine Risk: A Technical Walkthrough risk-assessment	0	271	December 20, 2025
⚖️ Risk assessment not strong enough, specifically on related impurities containing secondary amine	24	2479	September 25, 2025
Stability in risk assessment report risk-assessment	12	675	September 10, 2025
Call to review USP Risk Assessment Review Toolbox	125	3867	August 20, 2025
Background on Purging Factor Calculation for your Risk Assessment featured , purge	7	1829	August 13, 2025
Nitrosamine Risk Mitigation Calculator (by DFE Pharma) NDSRI , featured	1	1504	August 11, 2025
Nitrosamines evaluation in transdermal patches	12	2182	July 16, 2025
CMO Nitrosamine Risk Assessment Drug_Substance_APIs , NDSRI , risk-assessment	7	546	June 27, 2025
How to decide if one anticancer drug is for advanced cancer? risk-assessment	12	815	June 13, 2025
📖 Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines-Pub risk-assessment , featured	2	1152	May 27, 2025
Can we bypass confirmatory testing of DP based on Theoretical Calc. of NDSRI's	9	1556	April 24, 2025
Nitrosamines in topical products	4	1302	April 15, 2025
NDSRI in finishe products risk-assessment	2	455	March 13, 2025
N-nitrosoamides - a horse of a different color Drug_Substance_APIs	54	7807	March 6, 2025
Risk Assessment and Management Strategy of Two New Nitrosamine Drug Substance Related Impurities (NDSRIs) in a Pharmaceutical Drug Product for the Treatment of a Rare Disease- from Prediction to Control-Pub NDSRI	0	609	January 29, 2025
📽 Introduction to Using (Q)SAR for the Assessment of Potential Mutagenicity of Drug Impurities QSAR	0	295	October 30, 2024
🖥 Berkeley Madonna Software for Nitrosation Kinetic Calculations	5	911	October 10, 2024

Carcinogenic Potency Database - Access free

With discussions about limits and how they are establish, it’s an important reminder about the Carcinogenic Potency Database, now The Lhasa Carcinogenicity Database (LCDB). Below from Lhasa article: “5 things you should…